Financial Health Assessment: EMMS NAZARETH

1. Financial Health Score: B (Incomplete Examination)

Explanation: I am assigning a provisional grade of B, though it comes with a significant diagnostic caveat. Because the patient’s "blood work" (financial figures) is missing from this chart, a complete fiscal diagnosis is impossible. However, based on the visible symptoms—excellent compliance, a robust governance structure, and a long operational history—the organizational heartbeat is strong. The structural and administrative health is excellent, but the financial vitals remain opaque.

2. Key Vital Signs

• Pulse (Compliance & Filing Status): Strong and steady. The company’s accounts are made up to 31 December 2025, with the next deadline not until September 2027, and no overdue filings. This indicates a healthy administrative routine with no signs of regulatory distress.
• Blood Pressure (Financial Metrics): Unreadable. Without the quantitative data (turnover, assets, liabilities, cash flow), we cannot take the patient's financial blood pressure. We cannot assess liquidity, solvency, or operational efficiency.
• Immune System (Governance & Board Composition): Highly robust. The company boasts a large, multidisciplinary board of 15 current directors. The presence of medical professionals (Dr. DE CAESTECKER, Dr. HADDAD), legal oversight (Solicitor FIONA MOIRA AKERS), and financial expertise (Retired Finance Director WILLIAM NORMAN BENNETT) acts as a powerful immune system against mismanagement and strategic myopia.
• Corporate DNA (Company Structure): Mission-aligned. As a Private Limited by Guarantee with no share capital (PRI/LBG/NSC), the company is structured as a non-profit or charitable entity. This means there are no shareholders demanding dividends; instead, surpluses are reinvested into the mission ("Healing in the name of Jesus since 1861"). The lack of Persons with Significant Control (PSC) is normal for this structure, as control is tied to guarantee members rather than shareholdings.

3. Diagnosis

Based on the available qualitative data, EMMS NAZARETH is a structurally sound, mission-driven organization with no visible symptoms of administrative distress. The recent board transition (one director resigned in late 2025, another in early 2026) is a normal part of organizational life, akin to a healthy cell turnover, and does not suggest internal turmoil given the size of the board.

However, the absence of financial data in this examination is akin to a patient leaving the lab before drawing blood. Because the company files "Full" accounts (rather than claiming micro-entity or dormant exemptions), it is legally required to disclose detailed financial statements to Companies House. The fact that we lack these numbers here means we cannot diagnose the financial circulatory system—we cannot tell if cash flow is healthy or if the organization is suffering from a working capital deficiency.

4. Recommendations

To ensure continued organizational wellness and complete this diagnostic picture, I recommend the following course of treatment:

1. Order the Financial Blood Work: Retrieve the full, filed annual accounts from Companies House for the most recent financial year. Specifically, examine the Statement of Financial Activities (SOFA) to check income sustainability, and the Balance Sheet to ensure net current assets (working capital) are positive.
2. Monitor Board Transitions: With a large board of 15 members, ensure that recent and future departures are matched with strategic onboarding. The "immunological" strength of the board relies on maintaining its current diversity of medical, legal, and financial expertise.
3. Check Charitable Vital Signs: As a company limited by guarantee with a religious/medical mission, verify its status with the Office of the Scottish Charity Regulator (OSCR). Ensuring that charitable compliance and reporting are as healthy as Companies House compliance will protect the organization from regulatory fever.
4. Assess Cash Flow Respiration: Once the financials are obtained, calculate the current ratio (current assets divided by current liabilities). A ratio below 1.0 would indicate shortness of financial breath, meaning the organization might struggle to meet its immediate debts.